0001127602-24-010112.txt : 20240314
0001127602-24-010112.hdr.sgml : 20240314
20240314160342
ACCESSION NUMBER: 0001127602-24-010112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240313
FILED AS OF DATE: 20240314
DATE AS OF CHANGE: 20240314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASPER MARC N
CENTRAL INDEX KEY: 0001216055
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08002
FILM NUMBER: 24749680
MAIL ADDRESS:
STREET 1: C/O THERMO FISHER SCIENTIFIC
STREET 2: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERMO FISHER SCIENTIFIC INC.
CENTRAL INDEX KEY: 0000097745
STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 042209186
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 7816221000
MAIL ADDRESS:
STREET 1: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: THERMO ELECTRON CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-13
0000097745
THERMO FISHER SCIENTIFIC INC.
TMO
0001216055
CASPER MARC N
168 THIRD AVENUE
WALTHAM
MA
02451
1
1
Chairman & CEO
1
Common Stock
2024-03-13
4
M
0
10000
190.59
A
133816.462
D
Common Stock
2024-03-13
4
S
0
300
591.82
D
133516.462
D
Common Stock
2024-03-13
4
S
0
3593
593.01
D
129923.462
D
Common Stock
2024-03-13
4
S
0
2172
594.02
D
127751.462
D
Common Stock
2024-03-13
4
S
0
900
595.06
D
126851.462
D
Common Stock
2024-03-13
4
S
0
1662
596.49
D
125189.462
D
Common Stock
2024-03-13
4
S
0
1073
597.39
D
124116.462
D
Common Stock
2024-03-13
4
S
0
300
597.99
D
123816.462
D
Common Stock
11300
I
By Alison Casper 2020 Irrevocable Trust
Common Stock
43608
I
By Floral Park Associates, Inc.
Common Stock
5000
I
By MNC 2020 Irrevocable Trust
Stock Option (Right to Buy)
190.59
2024-03-13
4
M
0
10000
0
D
2021-03-07
2024-09-07
Common Stock
10000
56300
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $591.29 to $592.09, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $592.50 to $593.36, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $593.51 to $594.47, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $594.64 to $595.27, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $595.84 to $596.81, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $596.88 to $597.74, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $597.90 to $598.11, inclusive.
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
2024-03-14